Privia Health Group, Inc. (PRVA)

Nasdaq Health Care Health Care Services S&P SmallCap 600

$24.42

+0.48 (+2.01%)

Close of Nov 06, 2026 · end-of-day data

Source: Privia Health Group, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$786.36M	$817.08M	$966.22M	$1.36B	$1.66B	$1.74B	$2.12B
Operating income	$16.06M	$25.38M	-$217.44M	-$19.12M	$20.65M	$16.98M	$34.23M
Interest expense	$4.00M	$1.90M	$1.10M	$500.00K	—	—	—
Pre-tax income	$9.15M	$23.46M	-$218.51M	-$18.58M	$29.02M	$27.87M	$43.94M
Income tax	$1.21M	-$7.44M	-$27.86M	-$6.52M	$7.99M	$10.83M	$14.21M
Net income	$8.24M	$31.24M	-$188.23M	-$8.59M	$23.08M	$14.38M	$22.92M
EBITDA	$17.49M	$27.22M	-$214.97M	-$14.55M	$27.18M	$24.25M	$44.14M
EPS (basic)	$0.09	$0.33	$-1.83	$-0.08	$0.20	$0.12	$0.19
EPS (diluted)	$0.09	$0.33	$-1.83	$-0.08	$0.19	$0.11	$0.18
Diluted shares	95.93M	95.95M	102.95M	110.70M	124.69M	125.61M	128.89M
Operating margin	2.0%	3.1%	-22.5%	-1.4%	1.2%	1.0%	1.6%
Net margin	1.0%	3.8%	-19.5%	-0.6%	1.4%	0.8%	1.1%

Balance sheet

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$46.89M	$84.63M	$320.58M	$347.99M	$389.51M	$491.15M	$479.69M
Receivables	—	$99.12M	$117.40M	$189.60M	$290.77M	$316.18M	$400.90M
Total current assets	—	$190.08M	$446.68M	$551.96M	$700.80M	$834.82M	$911.00M
Goodwill	—	$118.66M	$127.94M	$126.94M	$138.75M	$141.62M	$209.84M
Total assets	—	$328.97M	$686.37M	$792.81M	$999.90M	$1.14B	$1.37B
Total current liabilities	—	$146.94M	$190.46M	$264.27M	$386.95M	$449.15M	$568.52M
Total liabilities	—	$185.32M	$236.19M	$273.76M	$392.51M	$452.34M	$578.43M
Shareholders' equity	$107.46M	$146.75M	$426.87M	$499.09M	$561.44M	$635.18M	$737.22M

Cash flow

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$24.36M	$38.89M	$55.06M	$47.20M	$80.78M	$109.28M	$163.40M
Capital expenditures	$5.71M	$380.00K	$547.00K	$104.00K	$113.00K	—	—
Free cash flow	$18.65M	$38.51M	$54.51M	$47.09M	$80.67M	$109.28M	$163.40M
Investing cash flow	-$5.71M	-$380.00K	-$32.77M	-$104.00K	-$42.97M	-$11.98M	-$181.57M
Financing cash flow	-$10.87M	-$767.00K	$213.66M	-$19.68M	$3.71M	$4.33M	$6.70M
Stock-based compensation	$207.00K	$484.00K	$253.53M	$67.36M	$37.10M	$56.68M	$71.07M
Depreciation & amortization	$1.43M	$1.84M	$2.46M	$4.57M	$6.53M	$7.27M	$9.91M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$440.83M	$415.24M	$422.33M	$437.92M	$460.90M	$480.10M	$521.15M	$580.42M	$541.17M	$603.85M	$632.63M	$656.96M
Operating income	$1.42M	$823.00K	$5.10M	$5.81M	$5.25M	$5.22M	$3.34M	$14.40M	$11.28M	$7.42M	$11.77M	$20.54M
Pre-tax income	$4.27M	$3.81M	$8.06M	$7.98M	$8.02M	$8.15M	$5.74M	$16.67M	$13.37M	$9.31M	$16.75M	$22.27M
Income tax	$1.94M	$751.00K	$3.42M	$4.00M	$2.65M	$2.10M	$2.46M	$6.87M	$2.79M	$5.60M	$7.02M	$7.67M
Net income	$2.84M	$2.98M	$3.47M	$3.54M	$4.40M	$4.22M	$2.69M	$6.86M	$9.15M	$3.06M	$9.05M	$13.49M
EBITDA	$3.19M	$2.64M	$6.92M	$7.61M	$7.08M	$7.12M	$5.92M	$17.17M	$13.94M	$10.70M	$15.13M	$24.04M
EPS (basic)	$0.03	$0.03	$0.03	$0.03	$0.04	$0.03	$0.02	$0.06	$0.08	$0.02	$0.07	$0.11
EPS (diluted)	$0.03	$0.02	$0.03	$0.03	$0.03	$0.03	$0.02	$0.05	$0.07	$0.02	$0.07	$0.10
Diluted shares	39.22K	125.05M	125.32M	125.75M	156.63K	127.75M	128.45M	128.78M	497.52K	130.88M	131.83M	132.71M
Operating margin	0.3%	0.2%	1.2%	1.3%	1.1%	1.1%	0.6%	2.5%	2.1%	1.2%	1.9%	3.1%
Net margin	0.6%	0.7%	0.8%	0.8%	1.0%	0.9%	0.5%	1.2%	1.7%	0.5%	1.4%	2.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$389.51M	$351.14M	$387.35M	$422.00M	$491.15M	$469.33M	$390.13M	$441.35M	$479.69M	$419.52M	$412.20M	$446.28M
Receivables	$290.77M	$346.09M	$370.06M	$408.96M	$316.18M	$388.73M	$443.99M	$499.04M	$400.90M	$513.68M	$574.16M	$623.58M
Total current assets	$700.80M	$728.14M	$779.67M	$853.75M	$834.82M	$886.47M	$882.96M	$970.93M	$911.00M	$966.02M	$1.03B	$1.10B
Goodwill	$138.75M	$139.46M	$139.46M	$139.46M	$141.62M	$141.62M	$172.22M	$172.22M	$209.84M	$209.84M	$215.79M	$215.79M
Total assets	$999.90M	$1.03B	$1.08B	$1.15B	$1.14B	$1.18B	$1.27B	$1.35B	$1.37B	$1.42B	$1.49B	$1.56B
Total current liabilities	$386.95M	$403.80M	$429.59M	$479.47M	$449.15M	$470.81M	$534.85M	$582.91M	$568.52M	$601.30M	$634.44M	$674.36M
Total liabilities	$392.51M	$408.76M	$434.01M	$483.38M	$452.34M	$474.01M	$539.00M	$588.23M	$578.43M	$611.99M	$650.51M	$690.80M
Shareholders' equity	$561.44M	$576.80M	$595.41M	$614.89M	$635.18M	$659.44M	$682.86M	$709.12M	$737.22M	$753.06M	$782.33M	$815.72M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$64.10M	-$33.14M	$34.47M	$33.15M	$74.80M	-$24.06M	$7.97M	$51.99M	$127.50M	-$49.47M	$1.10M	$28.94M
Capital expenditures	$23.00K	—	—	—	—	—	—	—	—	—	—	—
Free cash flow	$64.08M	-$33.14M	$34.47M	$33.15M	$74.80M	-$24.06M	$7.97M	$51.99M	$127.50M	-$49.47M	$1.10M	$28.94M
Investing cash flow	-$5.02M	-$5.71M	$0	$0	-$6.26M	$0	-$89.06M	-$1.20M	-$91.31M	-$26.00K	-$11.46M	-$1.07M
Financing cash flow	$42.00K	$475.00K	$1.75M	$1.49M	$619.00K	$2.24M	$1.88M	$431.00K	$2.15M	-$10.67M	$3.04M	$6.21M
Stock-based compensation	$11.67M	$11.90M	$14.39M	$15.11M	$15.28M	$17.79M	$18.85M	$18.98M	$15.45M	$21.92M	$19.40M	$14.03M
Depreciation & amortization	$1.77M	$1.82M	$1.82M	$1.80M	$1.83M	$1.90M	$2.58M	$2.77M	$2.66M	$3.28M	$3.36M	$3.50M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.